Skip to main content

$750M Verdict Against J&J In NJ Over Baby Powder

$750M Verdict Against J&J In NJ Over Baby Powder

$750M Verdict Against J&J In NJ Over Baby Powder

Introduction

On Thursday, a New Jersey jury ordered Johnson & Johnson (J&J) to pay punitive damages of $750 million to four plaintiffs, who alleged their talc-based baby powder caused cancer.

The verdict came after the first-ever testification of J&J's Chief Executive Alex Gorsky in the trial alleging the baby powder of causing cancer. J&J was held liable for the plaintiffs' cancer by a separate jury awarding them $37.2 million in compensation last September.

J&J stated that the judge is looking forward to reducing the damages to approximately $185 million. Plaintiffs lawyer Chris Placitella argued that punitive damages have to be five times the liability damages.

J&J said that they would appeal for both phases of the trial, claiming “numerous legal errors that subjected the jury to irrelevant information and prevented them from hearing meaningful evidence.”

J&J faces nearly 14,000 lawsuits against its products, Talcum Powder and Shower-to-Shower. All the lawsuits are centralised under multidistrict litigation MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation. Another set of lawsuits is consolidated before the district court judge of California under Judicial Council Coordinated Proceeding No. 4877.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!